focus -WSS

focus

author：fashion 2025-10-01 15:28:28 - browse：84

A person picking up medication at a drive through pharmacy window – biotech and pharma coverage from STAT — Adobe

On Tuesday morning, the Department of Health and Human Services unveiled its long-awaited list of the 10 medicines that will be subject to price negotiation in 2026 under the Inflation Reduction Act.

This will mark the first time that Medicare, the government program for paying for health care for older Americans, will have any ability to use its vast size to negotiate for lower prices. It’s not yet clear how big the discounts on these 10 drugs will be, or even if the law will hold up to multiple legal challenges from the pharmaceutical industry. It’s also not clear, as critics from the drug industry have noted, whether any savings to the government will be passed on to consumers.

Still, the naming of 10 medicines is a milestone, and a point to start appraising the impact of the law. The landscape here is complicated. No one really knows how the IRA’s price negotiation process will play out over the short and long term, and many companies who had products named were spared in other ways, with products many industry watchers expected to see on the list absent. Here is STAT’s assessment of who has won and lost.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Multiple sclerosis has subtypes with different best treatments: study

WSS

Bird flu reported in person exposed to presumably infected cattle

Novo Nordisk to expand supply of Wegovy for U.S. patients

Insurer loopholes limit power of law against surprise medical bills

Overprescribed: High cost isn't America's only drug problem

Do digital therapeutics have a future in medicine?

Bird flu in dairy cattle: New measures to control spread to humans

entertainment

focus

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Gut bacteria may contribute to kidney autoimmunity, study finds

Malaria cases in Florida and Texas: Here’s what you need to know

New Ultima Genomics DNA sequencer can read genome for $100

Heart attack and stroke risk calculators need revising

ARCH Venture Partners is raising $3 billion for a life sciences fund

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ARCH Venture Partners is raising $3 billion for a life sciences fund

ChatGPT in medicine: STAT answers readers' burning questions

Gut bacteria may contribute to kidney autoimmunity, study finds

explore

Pancreatic cancer is often deadly, but new discoveries are raising hope

Young boy dies in trial for Pfizer Duchenne gene therapy

Commercial surrogacy can be ethical, despite pope’s claims

Multiple sclerosis has subtypes with different best treatments: study

Time to name cancers by genetics, not organ of origin, expert says

Scientific mystery highlights the blind spots in genomics databases

entertainment

Wikipedia

hotspot

entertainment